CONSORTIUM
Biological Research, in particular, as it deals with the study of life, has a direct impact on key areas of human life such as health and the environment. In addition, due to the important achievements of the last decades and the high expectations for innovation in the future, organic research has gained a very important position worldwide in terms of both the value that public opinion gives and the rate of funding it absorbs and share of economic activity that is stimulating.
One of the main objectives of the Department is the production of new knowledge through the promotion of high level basic and – mainly – applied research. Moreover, the research activity of the Department – supported by both its human resources (faculty members, postgraduate and undergraduate students, postdoctoral researchers, etc.) and its appropriate logistic infrastructure (laboratories, instruments, computers, experimental instruments , etc.) is also the most important factor in upgrading the level of teaching and training offered.
The Laboratory of Pharmacognosy and Chemistry of Natural Products (LPCNP) of the Department of Pharmacy (University of Patras) is a multidisciplinary Laboratory, which emphasizes Chemical Science at the interface of Chemistry and Biology. Beyond the teaching duties in the graduate and post-graduate level, the major research focus of the LPCNP is the synthesis, the conformational analysis and the structure-activity studies on bioactive peptides and peptides analogues of therapeutic and/or diagnostic significance.
LPCNP is in operation since 1989 (Official foundation in 1995; Journal of the Hellenic Republic 38/22.02.95). The Laboratory had the privilege to constitute the basic Unit of a National Network of Laboratories granted from the First Operational Program of Research and Technology of Greece (Stride 1991-1994, Project 91). The main aim of the project was the creation of the Unit of Synthetic Peptides with the essential infrastructure for the promotion of the basic and mainly applied research on bioactive peptides of pharmaceutical importance.
NATIONAL HELLENIC RESEARCH FOUNDATION
Institute of Biology, Medicinal Chemistry & Biotechnology
The IBMCB was established in March 2012 as a result of the merger of the Institute of Biological Research and Biotechnology (IBRB) and the Institute of Organic and Pharmaceutical Chemistry (IOPC) of the NHRF. The objective of IBMCB is to act as a focal point of Excellence, through an interdisciplinary approach in the area of Chemical Biology with the aim of providing solutions for state-of-the-art issues in the areas of health, drug research, and biotechnology.
In Greece, no other Institute currently employs an analogous integrated multidisciplinary approach to disease prevention and treatment, combining cutting edge biological research (biological target identification, biological evaluation of bioactive agents) with synthetic and medicinal chemistry and molecular analysis (rational design and synthesis of bioactive compounds – potential drugs to combat major diseases and targeted delivery formulations).
The IBMCB aspires to play a key role, nationally and internationally, in research for drug discovery and biological target identification, as well as in research on high added-value fine chemicals, biotech products and processes, relying on the exploitation of the synergy between Chemistry and Biology, the expertise of its research staff and its significant state-of-the-art infrastructure.
BioAssist S.A. is a Greek ICT services company providing advanced home care services for elderly and chronic patients. By combining innovative technologies, BioAssist services aim to improve the quality of life of elderly people and people with chronic conditions by supporting their independent living. The company platform offers modern communication and networking features, real-time medical monitoring, and 24-hour monitoring and emergency response mechanisms. At the same time, the company’s services encourage the compliance of elderly and chronic patients with their treatment, while providing a sense of security to themselves and their families.
Boderm S.A invests in research in collaboration with universities and research centers in Europe for documentation of our products.We declare participation in International and European Dermatological Conferences ,exhibitions of raw materials, packaging, product development contributing to challenges of our industry.The common goal of Boderm and Boderm Laboratories is to continuously invest in innovative products with new technologies of interest to the international environment.
Boderm S.A, in recent years has invested in development, production and launch of Medical Devices, Food Supplements, Pharmaceuticals and Cosmeceuticals, The research center at the premises of Boderm Laboratories provide us flexibility and guarantee our early, valid and secure result of our products.
Boderm and Boderm Laboratories provide and accept proposals for research and product development within international product innovation challenge.